A new NCL-targeting aptamer-drug conjugate as a promising therapy against esophageal cancer
{{output}}
Esophageal cancer (EC) is one of the most common highly malignant tumors of the digestive system, with a poor prognosis under current treatment regimens. Nucleolin (NCL) is overexpressed in many tumors, and drugs specifically targeting NCL may offer a promisin... ...
